期刊文献+

抗生素治疗重症肺炎患者血清降钙素原的动态监测 被引量:5

Dynamic monitoring of serum procalcitonin in patients with severe pneumonia by antibiotic therapy
下载PDF
导出
摘要 目的分析动态监测血清降钙素原(PCT)在指导重症肺炎患者抗生素使用中的价值。方法选取192例重症肺炎患者,随机分为观察组和对照组各96例。观察组采用PCT指导抗生素治疗,对照组采用常规经验指导抗生素治疗。在治疗1、4、7 d及ICU转出前检测并比较2组血清PCT、白细胞计数(WBC)、C反应蛋白(CRP)水平。比较2组患者抗生素使用情况。结果 2组治疗不同时间点PCT水平均显著降低,且观察组PCT水平均显著低于对照组(P <0. 05)。2组WBC在ICU转出前显著下降(P <0. 05)。2组治疗后不同时间点CRP水平均显著降低(P <0. 05),且观察组治疗4、7 d后CRP水平显著低于对照组(P <0. 05)。观察组抗生素使用例数、抗生素使用时间、抗生素品种、抗生素使用强度、ICU停留时间均显著优于对照组(P <0. 05)。结论动态监测PCT水平可指导重症肺炎患者抗生素使用,提高抗感染治疗效果,降低抗生素用药时间和用药量。 Objective To analyze the value of dynamic monitoring of serum procalcitonin (PCT) in guiding the use of antibiotics for patients with severe pneumonia. Methods A total of 192 patients with severe pneumonia were randomly divided into observation group and control group, with 96 cases in each group. The observation group used PCT to guide antibiotic treatment, while the control group used conventional experience to guide antibiotic therapy. The levels of PCT, white blood cell count (WBC) and C reactive protein (CRP) were detected and compared at 1 st , 4 th , 7 th days of treatment and before the out of ICU. Antibiotic use was compared between the two groups. Results The levels of PCT at different time points reduced significantly in both groups ( P 〈0.05), and PCT levels at different time points in observation group were significantly lower than control group ( P 〈 0.05). The WBC in both groups decreased significantly before the out of ICU ( P 〈0.05). The levels of CRP significantly reduced at different time points in both groups ( P 〈0.05), and the levels of CRP at 4 th , 7 th days of treatment in the observation group were significantly lower than those in the control group ( P 〈0.05). The cases with antibiotic use, antibiotic use time, antibiotic varieties, antibiotic use intensity and time in ICU in the observation group were significantly better than those in the control group ( P 〈0.05). Conclusion Dynamic monitoring of PCT level can guide the use of antibiotics in patients with severe pneumonia, improve the effect of anti-infection treatment, reduce the medication time and dosage of antibiotics.
作者 章金鹏 ZHANG Jinpeng(Intensive Care Unit,Huanggang Central Hospital,Huanggang,Hubei,43800)
出处 《实用临床医药杂志》 CAS 2018年第19期91-93,共3页 Journal of Clinical Medicine in Practice
关键词 降钙素原 动态监测 重症肺炎 抗生素 应用价值 procalcitonin dynamic monitoring severe pneumonia antibiotics application value
  • 相关文献

参考文献11

二级参考文献126

  • 1常春,姚婉贞,陈亚红,刘振英,张晓伟.慢性阻塞性肺疾病患者急性加重期血清降钙素原水平的变化及临床意义[J].中华结核和呼吸杂志,2006,29(7):444-447. 被引量:94
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3052
  • 3CHIST-CRAIN M, JACCARD-SROLZ D, BINFISSER R, et al. Effect of procalcitionin-guided treatment on antilbi- otie use and outcome in lower respiratory tract infections : cluster-randomised, single-blinded intervention trial [ J ]. Lancet,2004,363 (9409) :600-607.
  • 4BOUADMA L,LUYT C E,TUBACH F,et al. Use of pro- calcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial) :a multicentre ran- domised controlled trial [ J ]. Lancet, 2010,375 ( 9713 ) : 463 474.
  • 5REINHART K, HARTOG C S. Biomarkers as a guide for antimicrobial therapy[ J. Int J Antimicrob Agents,2010, 36 (Suppl 2) :S17-21.
  • 6ALBRICH W C, DUSEMUND F, BUCHER B, et al. Effec- tiveness and safety of procalcitonin-guided antibiotic ther- apy in lower respiratory tract infections in " real life" :an international, muhicenter poststudy survey ( ProREAL ) [J]. Arch Intern Med,2012,172(9) :715-722.
  • 7LONG W, DENG X, ZHANG Y, et al. Procalcitonin guid- ance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia [ J ]. Respirology, 2011,16(5) :819-824.
  • 8抗菌药物临床研究指导原则.中国临床药理学杂志,1987,2:126-130.
  • 9Venkatesh B, Imeson L, Kruger P, et al. Elevated Plasma Free Cortisol Concentrations and Ratios Are Associated With Increased Mortality E- ven in the Presence of Statin Therapy in Patients With Severe Sepsis [J]. Crit Care Med,2014.
  • 10Crim C, Dransfield MT, Bourbeau J, et al. Pneumonia Risk with In-haled Fluticasone Furoate and Vilanterol Compared with Vilanterol A- lone in Patients with COPD[J]. Ann Am Thorac Soc,2014.

共引文献1592

同被引文献53

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部